Overview
Gregory Long is an Oncologist practicing medicine in Pittsburgh, Pennsylvania.
His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Large-Cell Lung Carcinoma, EGFR Positive Lung Cancer, and Squamous Cell Lung Carcinoma.
He is actively involved in clinical research, co-authoring 2 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- HMO
- INDEMNITY
- POS
- PPO
Locations
320 E North Ave Ste 560, Pittsburgh, PA 15212
601 Colliers Way, Weirton, WV 26062
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
AHN Cancer Institute-Med Onc & Infusions At Allegheny General Hospital
Nathan Bahary MD, PhD received his B.A. from Cornell University, an M.D. from the Cornell University School of Medicine, and his Ph.D. from the Rockefeller University. He completed his residency at Beth Israel Hospital in Boston. He did his postgraduate training at the Dana Farber Cancer Institute, Harvard, and Brigham and Women’s Hospital system before joining the faculty of UPMC as the Director of the Pancreatic Cancer Center. Since 2021, he is the Division Chief of Medical Oncology at AHN Cancer Institute and Director of AHNCI Clnical Research. Amongst his various appointments Dr. Bahary is a member of the NCI Pancreatic Task Force, the Eastern Cooperative Oncology Group (ECOG) where he serves on the ECOG GI Steering Committee and the American Society of Clinical Oncology (ASCO) His basic research interests lie in the intersection between gastrointestinal development, metabolic stress pathways, immunology, and cancer. He has a broad research background in cancer genetics, developmental biology, molecular biology, and clinical investigations, with specific training and expertise in key research areas broadly within the field of gastrointestinal oncology, and specifically within pancreatic cancer. Building on his work at Harvard Medical School, Dr. Bahary is using insights gained by studying vertebrate development to determine how cancers grow. Clinical trials emanating from this research will continue at AHN Cancer Institute and are expected to lead to the development of new targeted agents and immunologic strategies for treating cancer. Dr. Bahary is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Bahary is board certified in Medical Oncology, American Board Of Internal Medicine.
UPMC Presbyterian
Jason Luke is an Oncologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Luke is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Melanoma, Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, and Liver Embolization.
Office
Leonard Appleman is an Oncologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Appleman is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, and WT1-Related Wilms Tumor Syndromes.
Frequently Asked Questions about Dr. Gregory Long
How do I make an appointment with Dr. Gregory Long?
You can book an appointment with Dr. Gregory Long by calling their office at 412-359-6220. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Gregory Long a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gregory Long is classified as an Experienced expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Gregory Long specialize in?
While Dr. Gregory Long is a Oncology, they have specific expertise in Non-Small Cell Lung Cancer (NSCLC), Large-Cell Lung Carcinoma, and EGFR Positive Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Gregory Long participate in research or clinical trials?
Yes. Dr. Gregory Long has published 2 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Dr. Gregory Long's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Gregory Long accept my insurance?
Dr. Gregory Long accepts most major insurance plans, including CareSource and Humana. We recommend calling the office directly at 412-359-6220 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer
- Autoimmune Hemolytic AnemiaDr. Long isExperienced. Learn about Autoimmune Hemolytic Anemia.
- Breast CancerDr. Long isExperienced. Learn about Breast Cancer.
- Dubin-Johnson SyndromeDr. Long isExperienced. Learn about Dubin-Johnson Syndrome.
- EGFR Positive Lung CancerDr. Long isExperienced. Learn about EGFR Positive Lung Cancer.
- Gallbladder AdenocarcinomaDr. Long isExperienced. Learn about Gallbladder Adenocarcinoma.

